Related Experiment Videos
Increased nitric oxide production in patients with systemic sclerosis
1Department of Internal Medicine, Rheumatology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, India 160012. asud@doctor.com
Nitric Oxide : Biology and Chemistry
|January 5, 2001
Summary
Systemic sclerosis (SSc) patients show elevated nitric oxide (NO) production, indicated by higher serum nitrite and citrulline levels. These markers did not significantly differ between SSc subgroups or correlate with systemic involvement.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Background:
- Nitric oxide (NO) is a key signaling molecule implicated in inflammatory and autoimmune conditions.
- Elevated NO production is observed in various inflammatory diseases, suggesting its role in pathogenesis.
Purpose of the Study:
- To investigate NO production in systemic sclerosis (SSc) by measuring serum nitrite and citrulline levels.
- To explore correlations between NO markers and disease characteristics in SSc patients.
Main Methods:
- Serum nitrite and citrulline levels were quantified in 34 SSc patients and 20 healthy controls.
- Statistical analyses were performed to compare groups and assess correlations with clinical parameters.
Main Results:
- SSc patients exhibited significantly higher serum nitrite (P < 0.001) and citrulline (P = 0.005) levels compared to controls.
- No significant differences in NO markers were found between limited and diffuse SSc subtypes or based on systemic involvement.
- A trend suggested a correlation between higher nitrite levels and impaired lung function (P = 0.07).
Conclusions:
- Evidence suggests increased NO production in patients with systemic sclerosis.
- NO levels do not appear to differ significantly across SSc disease subtypes or with systemic involvement.